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Summary
Background: Current protocols stress the importance of short-term diagnosis and treatment
in recent TIA or minor stroke. The risk of a recurrent event can be predicted with embolus
detection. Studies have shown that the presence of micro-emboli is associated with an increased
risk of recurrent events. We explored in our patient population the effect of a zero-tolerance
regime for cerebral embolism on outcome.
Methods: Patients with a recent TIA or minor stroke were assigned to a study group or control
group. Both groups were treated according to European Stroke guidelines, including prompt
start of anti-thrombotic therapy, statins and short-term carotid arteries duplex scanning. The
study group was subjected to TCD (Delica 9 series, Shenzen Delicate Electronics Co., LTD.,
China) embolus detection as soon as possible (EDS, SMT Medical, Wuerzburg, Germany). If emboli
were detected, treatment was started immediately to stop cerebral embolization. This was
achieved by either an altered drug regimen (clopidogrel) or angioplasty or carotid endarterec-
tomy within one or two days. If carotid intervention was indicated in the control group, it was
performed within two weeks, according to European guidelines.
Results: 133 patients were enrolled in the study with three months follow-up. 61 patients were
subjected to the control group, 72 patients were enrolled in the study group. Recurrent events
occurred in 10.2% and 3.0%, respectively (p = 0.145).
Conclusion: The current study shows a non-signiﬁcant reduction in recurrent events in the study
group. Probably sample size in this pilot study was insufﬁcient to detect a signiﬁcant decline.
Nevertheless, the results show that embolus detection is feasible and the zero-tolerance regime
may enhance the outcome of TIA and minor stroke patients. The ﬁndings support the start of a
multicenter randomized trial to assess the clinical value of emboli detection in TIA and stroke
care.
 acces© 2012 Elsevier GmbH. Open∗ Corresponding author.
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wo-fold: ﬁrst to promote full recovery of patients with
eurological deﬁcits and secondly prevention of stroke
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recurrence. Stroke recurrence can be divided in early and
late stroke recurrence. Recent literature has shown that
early stroke recurrence is seen especially within the ﬁrst
two weeks after the ischemic event. Age, blood pressure,
clinical presentation and duration of symptoms are known
predictors of stroke recurrence in this patient group. Diag-
nostic procedures such as duplex of the carotid arteries and
transcranial Doppler (TCD) of the middle cerebral artery
may enhance the prediction of early stroke risk recurrence
as high grade carotid artery stenosis in combination with
ongoing cerebral embolism is a strong independent risk
factor of stroke recurrence [1,2]. Although duplex exami-
nations have been implemented in current stroke protocol
for screening high-risk individuals, TCD embolus detection
has till date not gained a prominent place in screen-
ing TIA and stroke patients to evaluate the stroke risk
recurrence. Nevertheless there are a number of potential
advantages of embolus detection in stroke care. First it
may reassure embolus negative patients. Secondly it may
speed up the process of source location and treatment in
embolus positive patients and ﬁnally it may reﬁne indica-
tions for carotid artery surgery. To evaluate the efﬁcacy
to prevent stroke recurrence of embolus detection in a
clinical setting we designed this pilot study. Basically we
explored the effect of a zero-tolerance regime for cere-
bral embolism on outcome. The gathered data may be used
for future design of clinical trials that will prove or dis-
approve the value of embolus detection in TIA and stroke
care.
Methods
Study design
To study the outcome patients with a recent (>6 weeks)
carotid artery TIA or minor stroke were subjected to either
a conventional duplex-guided protocol (control group) or
a TCD embolus detection guided protocol (study group).
Minor stroke was deﬁned as a modiﬁed Rankin disability
score between 0 and 2 [3]. The randomization of patients
was not determined by chance but by availability of vas-
cular technologist which could perform the TCD embolus
detection (pseudo-randomization). Both groups followed the
internationally accepted guidelines of the European Stroke
Organisation [4]. This included a prompt start of an anti-
thrombotic drug regime in every patient and a rapid (<48 h)
duplex scanning.
Patients in the study group were subjected to a 30min
TCD embolus detection of the symptomatic middle cere-
bral artery to detect micro-embolic signals (MES). If patients
showed positive embolism in relation to an unstable carotid
artery stenosis, the carotid surgery or angioplasty was per-
formed within 48 h. In case of positive embolism without
a known embolic source clopidogrel was administered. If
patients within the control group exhibit a symptomatic
carotid stenosis or if patients in the control group exhib-
ited a symptomatic carotid stenosis without MES, surgery or
angioplasty was performed at the time interval advised by
the guidelines of the European Stroke Organisation (within
two weeks).
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Patients contacted the hospital either by an admission at
he emergency department or were referred by their house
hysician at the outpatient TIA and stroke clinic. Patients
ith an ischemic event of more than six weeks ago were
xcluded for this study. All patients were followed up for
hree months.
reatment protocol
he protocol included a prompt start of an anti-thrombotic
rug regime in every patient (300mg acetylsalicylic acid
or 14 days in case of a minor stroke or an initial dose
f 300mg acetylsalicylic acid on day 1 followed by a pre-
cription of 100mg daily in TIA patients). All patients
nderwent laboratory examinations, ECG, duplex exam-
nation of the carotid and vertebral arteries and a CT
nd/or MR of the brain. If duplex revealed a stenosis of
ore than 50% or the TCD embolus detection revealed
ctive cerebral embolism a CT angiography was performed
rom the aortic arc including the basal arteries of the
rain.
Therapeutic drug interventions included the prescrip-
ion of anti-thrombotic drug such as acetylsalicylic acid in
ombination with dipyridamole acid (in case of atrial ﬁb-
illation: anti-coagulants), statines and anti-hypertensive
reatment. Patients used clopidogrel for six months; in
ase of persistent cerebral embolization (for instance after
arotid surgery or when cerebral embolism was still present
fter the administration of acetylsalicylic acid) the drug
egimes were switched to a combination of anti-thrombotic
rugs that more effectively reduced the level of cerebral
mbolism.
arotid interventions
n case of a symptomatic carotid stenosis patients
ere asked to participate in the International Carotid
tenting Study (ICSS). The ICSS is an international mul-
icenter trial which compares the efﬁcacy of stenting
ersus surgery in the treatment of symptomatic carotid
rtery stenosis [5]. Patients scheduled for stent were
reated with clopidogrel for at least six months, after
arotid surgery they received acetylsalicylic acid and
ipyridamole acid. Patients scheduled for surgery and
tenting were observed for two days at the stroke
nit.
Monitoring during stent procedure was done in awake
atients by a neurologist. During carotid surgery the patients
ere exposed to general anesthesia and monitored by a clin-
cal neurophysiologist. Monitoring techniques during surgery
ncluded both TCD and electro-encephalography. Based on
onitoring results patients were electively shunted during
he carotid endarterectomy. TCD monitoring was performed
n all patients in the ﬁrst hours after surgery and stent-
ng procedures to detect persistent cerebral embolism or
alignant cerebral hyperperfusion. All patients underwent
full neurological exam on regular time intervals after the
tent or surgery until they were discharged from the stroke
nit.
2 R.W.M. Keunen et al.
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Table 1 Inclusion data of all patients.
Numbers Study
group
Control
group
72 61
General aspects
Age (yrs) 71.3 70.4
Ratio (female: male) 0.21 0.47
Modiﬁed Rankin score 0.59 0.61
Risk factors
ABCD2 score 4.6 4.3
Clinical presentation
Retinal events 17% 15%
Cortical events (aphasia) 30% 21%
Subcortical events (motor/sensory) 53% 64%
Duplex/CTA ﬁndings
Carotid stenosis < 70% or no stenosis 72% 76%
Carotid stenosis > 70% or occlusion 28% 24%
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ata sampling
he following information on patient history was obtained:
IA and minor strokes we classiﬁed into the following cate-
ories: retinal TIA, cerebral TIA or stroke. Documented were
he nature of the events such as visual, pure motor, pure sen-
ory, dysarthria, dysphasia, ataxia, apraxia or combination
f events. ABCD2 scores were obtained in all patients [6].
RI ﬁndings were classiﬁed into cortical infarcts, subcortical
nfarcts and leucoaraiosis. Infarcts were further subdivided
nto recent or non-recent and left or right sided. The side,
everity of the stenosis and presence of plaque ulceration
n duplex and CTA were documented as well. Further-
ore, blood pressure was documented as well as the current
se of anti-thrombotic drugs or anti-coagulants. Documen-
ation of the TCD embolus detection included: the side
f insonation, the peak systolic-, mean and end-diastolic
elocity, the duration of the measurement and the pres-
nce or absence of cerebral embolism by human experts. If
xperts found cerebral embolism the following parameters
f that embolus were noted: velocity, phase of cardiac cycle
systolic/diastolic) in which the events occurred, intensity,
uration and a parameter related to the musical character-
stics of the embolus (the zero-crossing index) [7].
Data of stent procedures and surgery were prospec-
ively documented including the occurrence of neurological
r non-neurological complications. The follow-up at three
onth included a neurological visit at the outpatient clinic.
ocumented were the TIA and stroke recurrence rate. If
omplications had occurred in the post-operative phase of
ngioplasty or surgery they were evaluated including the
ccurrence of new medical events in the last three months.
All data were stored in a downloadable Internet
ased electronic management system which allowed
nline statistical analysis of all included case records.
his data management system has been developed
y Mediwebdesign© The Netherlands (http://www.
ediwebdesign.nl/spi/stroke/loginreal.php).
mbolus detection by TCD
TCD Delica 9 series (Delicate/Shenzen/China) equipped
ith a 2MHz TCD transducer and a notebook PC (Acer®,
spire 1800 Series) were used for this study. A special Del-
cate headband was used to hold the 2MHz transducer,
hich allowed hands-off monitoring. The insonated artery
as the middle cerebral artery at its origin, just lateral
f the terminal internal carotid artery, on the ipsilateral
ide of the symptomatic carotid artery territory. Patients
ere monitored for 30min. In case of positive embolism the
ther contra-lateral middle cerebral artery was examined to
stimate whether the cerebral embolism was a uni-lateral
r bilateral phenomenon. Insonation depth varied between
5mm and 55mm. Patients were asked to not speak or move
heir head during the monitoring session because angular or
ateral probe movements may induce false positive embolic
vents.
To facilitate reliable embolus detection at the Haga
eaching Hospitals we developed an embolus detection sys-
em (EDS, SMT Medical, Wuerzburg, Germany) specially
esigned to detect the low intensity micro-embolic signal
r
f
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bIntervention
Surgery or angioplasty 23% 30%
een in TIA and stroke patients [7]. The EDS is a univer-
al software package that can be used on every ultrasound
ystem. On the basis of a neural network technology it clas-
iﬁes every intensity increase into MES or artefacts. The EDS
llows full veriﬁcation of the whole time series and has an
xport function which for instance allows consultation of a
ellow colleague over the Internet. The ﬁnal classiﬁcation
f the outcome of the EDS was done by two human experts
hich evaluated every event in both the embolus and arte-
act list. Human experts now decided whether the embolus
n the embolus list was a true embolus or a false positive
ne. The same has been done for the artefact event list.
n this list they searched for the presence of so called false
egative embolus (which is an embolus in the artefact event
ist that has not been correctly classiﬁed by the EDS). On
he basis of these examinations they ﬁnally decided: ‘active
erebral embolism’ or ‘no active embolism’.
tatistical analysis
ategorical values were presented as numbers (percent-
ges). Because of the limited number of observations
tatistical analysis were not supplied for Tables 1—4.
ndependent t-test was used to evaluate stroke and TIA
ecurrence for the control and the study group (whose distri-
utions approximate normality). Statistical signiﬁcance was
onsidered at P < 0.05. SPSS (v 17.0) statistical software was
sed for statistical analysis.
thical aspects
nformed consent was given by all patients. They were
xplained about the observational nature of the study
nd were informed about the rapid and regular treatment
egimes. They gave also consent for the three months
ollow-up monitoring. The study has been submitted to the
entral Committee on Research involving Human Subjects
ut according to their guidelines ethical approval was not
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Table 2 Epidemiological data of the study group.
Numbers 11 61
General aspects
Age (yrs) 73 76
Male sex 55% 85%
Female sex 45% 15%
Modiﬁed Rankin score (mean) 0.36 0.45
Risk factors
ABCD2 score (mean) 4.6 5.5
Clinical presentation
Retinal events 27.3% 14.7%
Cortical events (aphasia) 27.3% 24.5%
Subcortical events 45.4% 63.8%
Duplex/CTA ﬁndings.
Carotid stenosis > 70% or occlusion 72.7% 31.1%
CT/MRI ﬁndings
Table 4 Outcome of the study group.
Embolic activity Pos Neg
Numbers 11 61
Timing of therapeutical intervention
after EDS (days)
1.6a 14.0
Outcome at three month
TIA recurrence rate 0% 1.6%
Stroke recurrence rate 0% 1.6%
Sum TIA and stroke rate 0% 3.2%
a
R
B
P
f
i
s
s
oRecent ipsilateral infarcts (%) 18.8% 22.9%
required for this study because the patients were not ran-
domized into different treatment regimes. Merely patients
were given the opportunity to participate in a new diagnos-
tic procedure which was implemented at the Haga Teaching
Hospitals. Both rapid and regular treatment protocols fol-
low the current stroke guidelines of the European Stroke
Organisation [4].
Table 3 Epidemiological aspects of the cerebral MES.
Embolic frequency TIA
and stroke patients
Mean 3.4 (range
1—12)/30min
Embolus characteristics
Total number of MES 36
Mean intensity (dB) 3.8 (range 3.1—6.3)
Mean duration (ms) 35.7 (range 11.0—57.6)
Mean zero-crossing
index
13.2 (range 2.6—40.2)
Mean velocity and
(cm/s)
35.4 (range 10—53)
Ratio embolus in
systolic and diastolic
phase
1:12
Embolic sources
Internal carotid artery
origo stenosis
9 out of 11 patients
Carotid siphon stenosis 2 out of 11 patients
Cardiac source 0 out of 11 patients
Embolic activity 2—5 days after treatment
Drug switch from
Aspirin to Clopidogrel:
complete
disappearance in
2 out of 2 patients
Carotid surgery
complete
disappearance in
2 out of 2 patients
Carotid angioplasty
complete
disappearance in
7 out of 7 patients
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treated within the time of 48 h.
esults
aseline data
atient inclusion started on 1.8.2008 to 31.12. 2009, the
ollow up was ﬁnished on 1.4.2010. 133 patients enrolled
n the study with three months follow-up. 61 patients were
ubjected to the control group, 72 patients enrolled in the
tudy group. All patients could be evaluated to establish
utcome. Table 1 shows the data of both patient groups.
he table shows that both groups have more or less similar
asic demographic parameters. In the control group there is
preponderance of women compared to the study group.
ge, modiﬁed Rankin scores, ABCD2 scores, clinical pre-
entation, duplex ﬁndings and frequency of carotid surgery
nd/or angioplasty showed similar distributions.
pidemiology of cerebral embolism
able 2 gives speciﬁc data of the study group and shows
he relationship between clinical data and the presence or
bsence of cerebral embolism. Table 2 shows that cerebral
mbolism in this patient cohort was associated with a high-
rade internal carotid artery stenosis. Retinal events and
phasia were more frequently seen in patients who experi-
nced cerebral embolism.
Table 3 shows the epidemiology of cerebral embolism.
t showed a wide range of frequencies of emboli during
he 30min monitoring. Most emboli were short lasting, low
ntensity events that occurred in the diastolic phase of the
ardiac cycle. The emboli had a very prominent musical
ound expressed by the low zero-crossing index. The most
rominent source of the embolus was an internal carotid
rtery stenosis. In most patients the internal carotid artery
tenosis was located at the origin of the vessel. In two out of
leven patients the stenosis was located at the level of the
arotid syphon. The embolic activity decreased after ther-
peutical interventions such as carotid surgery, angioplasty
nd a drug switch from aspirin to clopidogrel.
utcomeable 4 shows the outcome of the study protocol in relation
o positive and negative embolism. Table 5 shows the out-
ome of both the control and study group. Table 4 shows
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Table 5 Outcome for all patients.
Number Study
group
Control
group
p-Value
72 61
Timing of therapeutical
intervention after event
(days)
24 22
Angioplasty 11.2% 13.1%
Carotid surgery 11.2% 14.8%
Total number 22.4% 27.9%
Outcome at three months
Modiﬁed Rankin score
(mean)
0.39 0.25 n.s.
TIA recurrence rate 1.4% 6.3%
Stroke recurrence rate 1.6% 4.9%
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recurrence
3.0% 10.2% 0.145
hat the diagnosis and treatment of patients with posi-
ive cerebral embolism was performed much faster than
he diagnosis and treatment of patients without cerebral
mbolism. Stroke and TIA recurrence rate in both groups
ere very low (respectively 0.0% and 3.2%). In the study
roup, one patient experienced a stroke recurrence in the
psilateral posterior cerebral artery resulting in a permanent
emi-anopsia. In the control group four recurrent strokes
ere observed. All these events occurred in the ipsilat-
ral middle cerebral artery territory; two of these events
ccurred in the post-operative phase of carotid surgery. One
f these events was classiﬁed as a possible cerebral hyper-
erfusion syndrome.
iscussion
pencer was the ﬁrst investigator who showed that detec-
ion of cerebral embolism was possible with TCD [8]. His
nitial study describes the ongoing cerebral embolism in
atients scheduled for carotid surgery. Soon after his pub-
ication the ﬁrst reports appeared about MES signals in TIA
nd stroke patients. In the last ten years a number of stud-
es showed unequivocal that ongoing cerebral embolism in
arotid artery disease is a strong independent predictor of
troke [1,2]. The current clinical study tried to explore the
otential of embolus detection to enhance the outcome of
atients with symptomatic carotid artery disease. Brieﬂy
ummarized this study revealed a non-signiﬁcant reduction
n recurrent events in the study group. Probably sample size
n this pilot study was insufﬁcient to detect a signiﬁcant
ecline. Nevertheless, the results show that embolus detec-
ion is feasible and the zero-tolerance regime may enhance
he outcome of TIA and minor stroke patients. The ﬁndings
upport the start of a multicenter randomized trial to assess
he clinical value of embolus detection in TIA and stroke
are.
During this study we observed that some patients with
low ABCD2 score may exhibit ongoing cerebral embolism
nd other patients with high score ABCD2 scores did not
lways show cerebral embolism and vice versa. It seems that
oth methods could in a way be complementary as the EDS
t
w
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esults are more indicative for plaque stabilitywhile some of
he ABCD2 score components are more indicative for plaque
ormation (such as age, blood pressure and diabetes).
This study showed that EDS monitoring can be used for
iagnosis and monitoring unstable carotid artery disease
nd gave insight in the epidemiology of cerebral embolism.
ES were seen during the diastolic phase of the cardiac
ycle and disappeared by anti-thrombotic drugs or plaques
emoval. The aforementioned aspects of the MES could best
e explained by the hypothesis that these MES were gen-
rated by small solid particles that were disloged into the
irculation by unstable carotid artery stenosis [9]. In some
atients we noted >12 MES in 30min which means that hun-
reds of these small particles must go to the brain within
24 h timeframe. Only a minority of these micro emboli
esulted in TIA’s or minor strokes. It seemed that the normal
rain has the capacity to clear these of tiny micro-emboli.
An important aspect is the duration of monitoring that
s needed to detect emboli. Previous studies showed that
mbolism is non-continuous phenomenon so it might be that
ery short observation times result in false negative moni-
oring results. The present study however shows that 30min
f monitoring gives relevant clinical information which, in
ombination with a zero-tolerance regime can, reduce the
troke recurrence rate. If the frequency of embolism is high
he observation time might be limited less than 30min. We
eel that the time that is needed to document at least two
ES is the minimum time for embolus detection. Future
tudies with ambulatory TCD systems will focus on the value
f extended embolus detection beyond the 30min [10].
This study showed that therapeutical interventions could
rrest ongoing cerebral embolism. This was observed after
ngioplasty, carotid stenting or after a drug switch to
lopidogrel. The latter is in accordance with the CARESS
rial [11] which showed that in patients with recently
ymptomatic carotid stenosis, combination therapy with
lopidogrel and aspirin is more effective in reducing asymp-
omatic embolism.
Although the number of observation are small in the
resent study Table 4 indicates a trend that patients who
xperienced cerebral embolism have a different vascular
roﬁle than those who do not exhibit cerebral embolism.
mbolus positive patients showed in contrast to embolus
egative patients more retinal and cortical TIA in combina-
ion with a symptomatic high-grade carotid artery stenosis.
atients without cerebral embolism presented often a sub-
ortical type of stroke or TIA and that these events are less
ften associated with a high-grade carotid artery stenosis.
herefore, it seems that embolus negative patients suffer
ore from a local thrombosis in relation to cerebral micro-
ngiopathy than carotid artery macro-angiopathy. However,
icro-embolism may still play a role in genesis of micro-
ngiopathy in embolus negative patients. It is important to
ealize that TCD cannot detect very tiny embolic particles.
he lower limit of TCD embolus detection is approximately
bout 0.3mm [12]. The diameter of the origin of the per-
orating arteries of the brain is around 0.2—0.8mm [13].
hus lacunar strokes could be the result of sub 0.3mm par-
icles which cannot be detected by TCD. The second reason
hy embolus negative patients may experience an embolic
troke is that the source of the embolus is located more
istal to the TCD sample volume. In this study the sample
[[
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volume was located around the origin of the MCA, while in
lacunar stroke the emboli may for instance arise from unsta-
ble microvascular lesions of the perforating arteries which
are located both distal and perpendicular to the sample vol-
ume. Therefore, the current TCD equipment will not answer
the question whether very small emboli can cause lacunar
and/or subcortical infarcts.
In summary at the HAGA Teaching Hospitals an embolus
detection system (EDS) has been developed with a spe-
cial focus to detect the short lasting, low intensity emboli
which can be observed in TIA and stroke patients. The
EDS can detect embolic activity in patients with a symp-
tomatic carotid stenosis and can be used as a monitor to
guard the safety and measure the efﬁcacy of treatment.
Reduction of cerebral embolism can be done by a num-
ber of interventions. Early prescription of anti-thrombotic
drugs, carotid surgery or angioplasty is established means to
arrest cerebral embolism. The outcome of the present study
shows that with the EDS approach very low recurrence rate
can be within range. The stroke recurrence rate at three
months for TIA and minor stroke has decreased over the
past ten years below the 5% level by the introduction of TIA
and stroke services; however, much effort will be needed
to achieve a further decrease. To achieve very low stroke
recurrence rates (between 0% and 1%), patients need to
be seen early after the event, high-risk individuals should
be identiﬁed rapidly and delivery of anti-thrombotic drug
regimes, surgery and angioplasty should be implemented
without delay. Randomized clinical studies are needed to
evaluate the clinical value of embolus detection in reducing
the stroke recurrence rate in TIA and stroke patients.
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